Cholesterol Guidelines Look High And Low: Statin Market Extended At Both Ends

In shifting away from specific targets and non-statin add-on therapies, new ACC/AHA cholesterol guidelines support treatment of people at relatively low risk for events and more intensive therapy for those at higher risk.

New cholesterol guidelines should expand the statin market from two directions: by pushing aggressive treatment for higher-risk patients and by extending recommendations for treatment to include patients at lower risk than previous versions.

Developed by the American Heart Association and the American College of Cardiology, the guidelines move away from numerical LDL cholesterol...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D